We are live on ! Find out more
TC

TFS Capital Portfolio holdings

AUM $255M
1-Year Est. Return 32.31%
This Fund
S&P 500
This Quarter Est. Return
+4.78%
1 Year Est. Return
+32.31%
3 Year Est. Return
+53.79%
5 Year Est. Return
10 Year Est. Return
AUM
$255M
AUM Growth
-$53M
Cap. Flow
-$59.9M
Cap. Flow %
-23.49%
Top 10 Hldgs %
4.95%
Holding
921
New
282
Increased
115
Reduced
203
Closed
319

Sector Composition

Rank Sector Weight
1 Healthcare 18.37%
2 Industrials 15.52%
3 Consumer Discretionary 13.06%
4 Technology 12.07%
5 Financials 7.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VBIV
551
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$99K 0.04%
759
+374
+97% +$50.5K
ARLZ
552
DELISTED
Aralez Pharmaceuticals Inc.
ARLZ
$97K 0.04%
+71,556
New +$103K
EIGR
553
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$96K 0.04%
+404
New +$91.8K
CGI
554
DELISTED
Celadon Group Inc
CGI
$95K 0.04%
+30,245
New +$94.7K
ARCO icon
555
Arcos Dorados Holdings
ARCO
$1.74B
$93K 0.04%
12,854
+396
+3% +$3.21K
ESXB
556
DELISTED
Community Bankers Trust Corporation
ESXB
$92K 0.04%
+11,122
New +$89.2K
NWY
557
DELISTED
New York & Co Inc
NWY
$92K 0.04%
66,730
+45,867
+220% +$70.1K
LYTS icon
558
LSI Industries
LYTS
$860M
$91K 0.04%
10,026
-10,201
-50% -$92.4K
RMT
559
Royce Micro-Cap Trust
RMT
$745M
$88K 0.03%
+10,200
New +$87.6K
CRHM
560
DELISTED
CRH Medical Corporation
CRHM
$88K 0.03%
+15,418
New +$100K
BCLI
561
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$87K 0.03%
+1,396
New +$86K
PCYO icon
562
Pure Cycle
PCYO
$255M
$86K 0.03%
+11,111
New +$80.1K
RIGL icon
563
Rigel Pharmaceuticals
RIGL
$681M
$86K 0.03%
3,142
-714
-19% -$19.5K
AXTI icon
564
AXT Inc
AXTI
$3.46B
$85K 0.03%
13,442
-60,212
-82% -$394K
GORO icon
565
Goldgroup Mining Inc.
GORO
$173M
$84K 0.03%
+20,527
New +$78.1K
NL icon
566
NLI Holdings
NL
$283M
$83K 0.03%
+11,707
New +$92K
QHC
567
DELISTED
Quorum Health Corporation
QHC
$83K 0.03%
19,964
-2,926
-13% -$12K
JNP
568
DELISTED
Juniper Pharmaceuticals, Inc. Common Stock
JNP
$83K 0.03%
16,490
-15,129
-48% -$67.7K
DWSN icon
569
Dawson Geophysical
DWSN
$148M
$80K 0.03%
21,400
+2,904
+16% +$12.7K
HBP
570
DELISTED
Huttig Building Products, Inc.
HBP
$79K 0.03%
11,244
-13,549
-55% -$99.5K
SIGM
571
DELISTED
Sigma Designs Inc
SIGM
$78K 0.03%
+13,265
New +$80.3K
CPSS icon
572
Consumer Portfolio Services
CPSS
$205M
$77K 0.03%
+16,959
New +$76.7K
OXSQ icon
573
Oxford Square Capital
OXSQ
$151M
$77K 0.03%
12,135
INTT icon
574
inTEST
INTT
$185M
$75K 0.03%
+11,270
New +$82K
LFVN icon
575
LifeVantage
LFVN
$79.1M
$75K 0.03%
+17,423
New +$76.8K

Similar funds

TFS Capital's Q2 2017 Portfolio in Review

As of Q2 2017, TFS Capital held 921 positions worth $255M, down 17% from $308M the previous quarter. Its ten largest holdings account for 4.9% of the portfolio.

TFS Capital withdrew a net $59.9M in Q2 2017, closing 319 positions and reducing 203 holdings. Its most notable exit was ePlus, an estimated $1.71M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, TFS Capital opened a new position in MYR Group worth $1.06M.

  • TFS Capital's largest Q2 2017 buy was MYR Group: 34,070 shares worth $1.06M.
  • TFS Capital added most to ModivCare in Q2 2017, an estimated $871K increase.
  • TFS Capital's biggest Q2 2017 reduction was Insight Enterprises, cutting an estimated $1.31M.
  • TFS Capital fully exited ePlus in Q2 2017, selling an estimated $1.71M.
  • TFS Capital's ten largest holdings make up 4.9% of its $255M portfolio in Q2 2017.
  • TFS Capital opened 282 new positions and closed 319 in Q2 2017.
  • TFS Capital's portfolio value fell 17% quarter-over-quarter to $255M.

Based on TFS Capital's 13F filing for Q2 2017, filed 11 Aug 2017.